NEW YORK (GenomeWeb) – Belgian molecular diagnostics company Biocartis announced today that it has taken a €40 million ($44 million) bank and lease financing facility and €15 million subordinated loan in order to finance the expansion of its manufacturing capacity for its Idylla diagnostics tests.

The company will also use part of the funds to refinance an existing loan of €5 million and to strengthen its financial position.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.